CNBC-TV18’s Archana Shukla caught up with Nilesh Gupta of Lupin on the sidelines of the pharma forum and asked him about the generic pharma market.
Certainly concerned about US generic market outlook. Concern is that established players like Sandoz, Teva are moving out, he said.
We are not looking at inorganic moves on the generic side at all, he added.
Only looking at technology or specialty acquisitions, he further mentioned.
For more, watch accompanying video…
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!